제1저자 또는 공저자로 매칭된 논문 · word-boundary on `authors` column
노드 더블클릭 = 해당 저자 페이지로 이동 · 호버 = 공저 횟수 툴팁
The recent clinical trials and regulatory approval of new antibody drug conjugates targeting HER2 protein (trastuzumab deruxtecan, T-DXd) has moved the bar in terms of therapy for breast cancer and other solid tumors. With new drugs and exp…